Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DNM1 | Q05193 | 4/20 | 0.44 |
| ▸ | HTT | P42858 | 2/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.44 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.42 |
| ▸ | RAD52 | P43351 | 1/20 | 0.42 |
| ▸ | BBOX1 | O75936 | 3/20 | 0.32 |
| ▸ | SLC22A1 | O15245 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL372742 | 0.83 | — | — | |
| SCHEMBL4950842 | 0.82 | DNM1 (0.42) | DNM1HTTKMT2AHSP90AA1RAD52 | |
| SCHEMBL15212441 | 0.80 | DNM1 (0.41) | DNM1HTTKMT2AHSP90AA1RAD52 | |
| Hydrochloric Acid SCHEMBL3783117 | 0.80 | — | — | |
| Bromide SCHEMBL10389897 | 0.80 | DNM1 (0.55) | DNM1HTTKMT2AHSP90AA1RAD52 | |
| Water SCHEMBL3058935 | 0.80 | — | — | |
| Bromide SCHEMBL9978605 | 0.80 | — | — | |
| Bromide SCHEMBL10389894 | 0.80 | DNM1 (0.60) | DNM1HTTKMT2AHSP90AA1RAD52 | |
| Bromide SCHEMBL9716395 | 0.80 | DNM1 (0.60) | DNM1HTTKMT2AHSP90AA1RAD52 | |
| Bromide SCHEMBL9716401 | 0.80 | DNM1 (0.55) | DNM1HTTKMT2AHSP90AA1RAD52 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2565886-A1 | Material for electrolytic solution, ionic material-containing composition and use thereof | Nippon Shokubai Co., Ltd. (JP) | 2013-03-06 | — | — | EP | disclosed |
| US-20080138704-A1 | Material for Electrolytic Solution, Ionic Material-Containing Composition and Use Thereof | NIPPON SHOKUBAI CO., LTD. (JP) | 2008-06-12 | — | — | US | disclosed |
| EP-1745525-A1 | MATERIAL FOR ELECTROLYTIC SOLUTION, IONIC MATERIAL-CONTAINING COMPOSITION AND USE THEREOF | Nippon Shokubai Co.,Ltd. (JP) | 2007-01-24 | — | — | EP | disclosed |
| WO-2005109562-A1 | MATERIAL FOR ELECTROLYTIC SOLUTION, IONIC MATERIAL-CONTAINING COMPOSITION AND USE THEREOF | NIPPON SHOKUBAI CO., LTD. (JP) | 2005-11-17 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080138704-A1 | Material for Electrolytic Solution, Ionic Material-Containing Composition and Use Thereof | ANO1, CLIC1, HCN1 | DNM1 2017/4885HTT 3840/4885KMT2A 3624/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.